Epidural Analgesia During Labour (PIEBvsPCEA)

August 2, 2018 updated by: MARIA BELEN RODRIGUEZ-CAMPOO, Hospital del Rio Hortega

Epidural Analgesia During Labour Randomized Clinical Trial Comparing Patient Controlled Epidural Analgesia Versus Patient Intermittent Epidural Boluses With Levobupivacaine

Randomized single blind trial based on comparing the way the local anesthetic is dosificated during labour. The pain control is evaluated and compared with both dosage techniques (PCEA vs PIEB)using levobupivacaine and fentanyl. The primary objective is to see no differences in pain control(VAS, Visual Analog Scale). The secondary goals are the differences in motor block(Bromage Scale), satisfaction (Likert Scale), the outcome (eutocic, instrumental o cesarean section), second stage of labour time, newborn´s Apgar and pH and total dosis and secondary effects of local anesthetic.

Study Overview

Detailed Description

There is a protocol where every healthy primiparous women have the chance to join the study after the explanation and the informed consent is signed. There are blind envelopes with the two kinds of treatment and the investigator only has to follow the protocol.

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Valladolid, Spain, 47012
        • Hospital Universitario Rio Hortega

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • 20- 40 years-old women
  • Primiparous women
  • Dilatation 3- 7 cm
  • No risk illnesses for epidural block
  • No risk pregnancy
  • Signed informed consent

Exclusion Criteria:

  • Illnesses which are a risk for pregnancy
  • Multiparous women
  • Contraindicated diseases for epidural block
  • Women who can not understand the procedure
  • Women who do not want to sign the informed consent
  • Patients with drug´s allergy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: PIEB (Patient Intermittent Epidural Bolus)

PIEB: The boluses are programmed every 30 minutes. The patient can ask for another extra bolus in between if she wishes.

The dosis per hour are equivalent to the PCEA. We make a comparison between PCEA vs PIEB.

Each patient were randomized to PIEB (7 ml bolus every 30 minutes, with extra boluses (PCEA) of 6 ml every 20 minutes) or PCEA (5 ml in continuous perfussion + PCEA of 5 ml every 15 minutes).
Active Comparator: PCEA (Patient continuous Epidural Analgesia)

PCEA: There is a continuous infusion and the patient can order extra boluses every 15 minutes.

The dosis per hour are equivalent to the other arm to the PIEB. We make a comparison between PCEA vs PIEB.

Each patient were randomized to PIEB (7 ml bolus every 30 minutes, with extra boluses (PCEA) of 6 ml every 20 minutes) or PCEA (5 ml in continuous perfussion + PCEA of 5 ml every 15 minutes).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VAS
Time Frame: 4 times after epidural block: previous, 1 hour after, 2 hours after, 15 minutes after delivery
Change from baseline in Visual Analog Scale
4 times after epidural block: previous, 1 hour after, 2 hours after, 15 minutes after delivery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction (Likert Scale)
Time Frame: 1 hour after delivery
1 (very satisfied), 2 (satisfied), 3 (no comments), 4 (not very satisfied), 5 (not satisfied at all)
1 hour after delivery
Bromage Scale
Time Frame: 15 minutes after Epidural Block and 1 hour after epidural block
15 minutes after Epidural Block and 1 hour after epidural block
Labour Outcome
Time Frame: Delivery
Eutocic
Delivery
Labour Outcome
Time Frame: Delivery
instrumental
Delivery
Labour Outcome
Time Frame: Delivery
cesarean section
Delivery
Expulsive time
Time Frame: From 10 cm of dilatation until delivery
From 10 cm of dilatation until delivery
Apgar at birth
Time Frame: 1 minute after birth
Apgar measured in 1 minute
1 minute after birth
Apgar at birth
Time Frame: 5 minutes after birth
Apgar measured in 5 minutes
5 minutes after birth
fetal pH at birth
Time Frame: 0 minutes after delivery
0 minutes after delivery
0 minutes after delivery
Total Dosis of Levobupivacaine
Time Frame: 0 minutes after delivery
miligrams
0 minutes after delivery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: M BELEN RODRIGUEZ-CAMPOO, Resident

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2015

Primary Completion (Actual)

September 1, 2017

Study Completion (Actual)

September 1, 2017

Study Registration Dates

First Submitted

September 12, 2016

First Submitted That Met QC Criteria

April 27, 2017

First Posted (Actual)

April 28, 2017

Study Record Updates

Last Update Posted (Actual)

August 6, 2018

Last Update Submitted That Met QC Criteria

August 2, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia, Obstetrical

Clinical Trials on PIEB: Patient Intermittent Epidural Boluses

Subscribe